Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (7)

« Back to Publications

Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer.

Falquet M. et al, (2026), Nat Commun

Neural anticipation of virtual infection triggers an immune response.

Trabanelli S. et al, (2025), Nat Neurosci, 28, 1968 - 1977

c-Met enforces proinflammatory and migratory features of human activated CD4+ T cells.

Benkhoucha M. et al, (2021), Cell Mol Immunol, 18, 2051 - 2053

PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions.

Ercolano G. et al, (2021), Nat Commun, 12

Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer.

Cachot A. et al, (2021), Sci Adv, 7

Syndecan-4 is regulated by IL-1β in β-cells and human islets.

Brioudes E. et al, (2020), Mol Cell Endocrinol, 510

Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients.

Rockinger GA. et al, (2020), J Immunother Cancer, 8